Drug distribution in tumors: mechanisms, role in drug resistance, and methods for modification.
about
Is inflammation a consequence of extracellular hyperosmolarity?Site-specific functionalization of proteins and their applications to therapeutic antibodiesTime-dependent stabilization of hypoxia inducible factor-1α by different intracellular sources of reactive oxygen speciesUltrasound mediated delivery of drugs and genes to solid tumors.The tumor microenvironment is a dominant force in multidrug resistance.Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapyUse of an orthovoltage X-ray treatment unit as a radiation research system in a small-animal cancer modelIncreased Expression of Several Collagen Genes is Associated with Drug Resistance in Ovarian Cancer Cell LinesTumor microenvironment and nanotherapeutics.The impact of tumor microenvironment on cancer treatment and its modulation by direct and indirect antivascular strategies.Hypoxic tumor microenvironment: Opportunities to develop targeted therapies.A "drug cocktail" delivered by microspheres for the local treatment of rat glioblastoma.The significance of lumican expression in ovarian cancer drug-resistant cell lines.Transcriptional profiling of NCI/ADR-RES cells unveils a complex network of signaling pathways and molecular mechanisms of drug resistance.Intrinsic and induced drug resistance mechanisms: in silico investigations at the cellular and tissue scales.A phase I trial of pantoprazole in combination with doxorubicin in patients with advanced solid tumors: evaluation of pharmacokinetics of both drugs and tissue penetration of doxorubicinThe Role of Matrix Gla Protein (MGP) Expression in Paclitaxel and Topotecan Resistant Ovarian Cancer Cell Lines
P2860
Q21245655-86C66051-3B27-4DD7-957D-BD501A242EC1Q26830699-5507E3A0-461D-4F23-A76E-330700E8E539Q28484609-5C831C15-9291-4CCA-B37B-65FFB007AE01Q30488681-0307B067-0772-4D52-83FC-E1E723A7903EQ36856829-5F6A6F04-338C-48FC-B1FC-15F4910705F0Q36952188-246B8738-165B-4AB9-ABD3-517EC0B93C94Q36980417-05A531E4-8131-427F-A655-85EAACA7B884Q37068010-AEBAEC37-9044-4B4F-A0D3-A6305897096AQ37632757-1D152A16-8900-47EF-B21B-94EA6ABC796CQ38028791-8EB889A7-FC4A-4951-B0F7-5FCD6AB53293Q38824983-ECAEF107-A37C-4FC5-980D-358080CAC93FQ45153266-B0816A44-CB1C-4E3F-96E3-D313AA96B9B3Q47132524-75CD65B0-0020-4126-8C7C-879F3E879E3AQ49594024-0C4737D2-383A-4A54-A91E-0F4FA1D3EE5AQ51833938-D48D9F19-4FA8-42F3-8224-B775640737F1Q57391487-62517344-246E-43C6-855E-02D638600877Q59138332-2E61FCAF-5DE9-44B4-858F-5554ED0235CC
P2860
Drug distribution in tumors: mechanisms, role in drug resistance, and methods for modification.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Drug distribution in tumors: m ...... and methods for modification.
@ast
Drug distribution in tumors: m ...... and methods for modification.
@en
type
label
Drug distribution in tumors: m ...... and methods for modification.
@ast
Drug distribution in tumors: m ...... and methods for modification.
@en
prefLabel
Drug distribution in tumors: m ...... and methods for modification.
@ast
Drug distribution in tumors: m ...... and methods for modification.
@en
P2860
P1476
Drug distribution in tumors: m ...... and methods for modification.
@en
P2093
Antonello Di Paolo
Guido Bocci
P2860
P2888
P304
P356
10.1007/S11912-007-0006-3
P577
2007-03-01T00:00:00Z